Prosecution Insights
Last updated: November 20, 2026
Application No. 18/293,248

COSMETIC COMPOSITION

Final Rejection §102
Filed
Jan 29, 2024
Priority
Aug 02, 2021 — JP 2021-126796 +1 more
Examiner
WEBB, WALTER E
Art Unit
1612
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Kao Corporation
OA Round
2 (Final)
46%
Grant Probability
Moderate
3-4
OA Rounds
6m
Est. Remaining
65%
With Interview

Examiner Intelligence

Grants 46% of resolved cases
46%
Career Allowance Rate
465 granted / 1007 resolved
-13.8% vs TC avg
Strong +19% interview lift
Without
With
+18.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
59 currently pending
Career history
1068
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
52.2%
+12.2% vs TC avg
§102
14.7%
-25.3% vs TC avg
§112
16.3%
-23.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1007 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicants' arguments, filed 10/02/2026, have been fully considered. Rejections and/or objections not reiterated from previous office actions are hereby withdrawn. The following rejections and/or objections are either reiterated or newly applied. They constitute the complete set presently being applied to the instant application. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-8, 12, 20 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Allard et al., (US 2009/0074701). Allard et al. teaches, applying to hair “a composition containing at least one silicone film forming resin, at least one polysilicone polymer, and at least one hair colorant” (Abstract). Regarding claim 2-3, “the silicone film former may be chosen from siloxysilicates. Preferably, the siloxysilicate is trimethylsiloxysiicate, which may or may not be in powder form” (p. 2, para. [0020]). “Suitable polysiloxane liquids include, but art not limited to . . . dimethicones” (p. 7, para. [0163]). Accordingly, the reference teaches a component B, i.e. a film forming polymer other than the component A. The prior art teaches a specific embodiment: PNG media_image1.png 726 452 media_image1.png Greyscale (p. 18). Here, the prior art teaches several embodiments that anticipate the instant claims, where all contain less than 0.5% or 0.1% of an oil gelling agent, as per claims 1 and 20. Example A comprises component (A) “Trimethylsiloxysilicate”, which is a MQ resin as per 1(A), (B) Nylon-611/Dimethicone, which suffices as film-forming polymer other than component A, and component C. 63% Isododecane (hydrocarbon-based volatile solvent; clm. 6). The content mass ratio of A over A+B [20%TMS/20%TMS+5% Nylon-611/Dimethocone, is about 80% [20/20+5], which falls within the claimed range of 10% or more and 90% or less, as per claim 4. The total content of component A and B for Example A above is about 25%, which is within the claimed range of 1% by mass or more and 40% by mass or less, as per claim 5. Since the prior art composition contains substantially the same components in the same relative proportions as instantly claimed, it would be expected to inherently possess the same chemical and physical properties, such as exhibiting a spreading area per 0.1 mL of 12 cm2 or more. The prior art is anticipatory insofar as it teaches a cosmetic composition comprising M unit (R1)3SiO1/2 and Q unit SiO4/2, i.e., trimethylsiloxysilicate; component B film-forming polymer; and 50% by mass or more of component C, a volatile solvent, e.g. isododecane, wherein the composition contains 0.5% by mass or less of an oil gelling agent. Technological Background 1) The prior art made of record and considered pertinent to applicant's disclosure Disapio et al., (International Journal of Cosmetic Science, 1988). Disapio et al. is pertinent for teaching, “Initially used in skin care products, and more recently in hair care applications, silicones are recognized for their lubricating properties and for the characteristic soft smooth feel they impart. With recent advances in silicone technology, these fluids can also provide substantivity and durability” (Summary) “In hair care products, organofunctional silicones, particularly those with amine functionality, provide substantive, durable conditioning properties. These properties can be related to the molecular weight and mole percent amine present. Conditioning properties are durable through a number of washes, yet the substantive films are -self-limiting and do not pose a problem of build-up” (p. 76, 3rd paragraph). 2) The prior art made of record and considered pertinent to applicant's disclosure Glenn Corp (BRB TMS-5OI, May 2015). Glenn Corp is pertinent for teaching features and benefits of Trimethylsiloxysilicate in isododecane, i.e., BRB TMS-5OI, which “can be used in a wide range of personal care applications such as Colour cosmetics, Sun care, Hair Care, antiperspirants and deodorants” (Application). Features and benefits include: “Due to the high volatility of isosodecane, the solvent quicklyevaporates during application leaving behind a water insoluble highly durable film of trimethylsiloxysilicate”; “Wash-off and rub-off resistant, long lasting effect”: “Hair Care: fixative, frizz control” Response to Arguments Initially, the declaration of Tomoka Maekawa, filed 10/02/2026, is acknowledged. Affiant provided a showing where the presence of 12-Hydroxystearic acid at an amount greater than 0.5% reduced the ease of applying and spreading the cosmetic. Although the prior art uses disteardimonium hectorite instead of 12-Hydrocystearic acid, Affiant postulates, “both materials are oil gelling agents and have a common mechanism of action in that they structure the oil phase to form a gel” (p. 4). Nevertheless, the claims have been amended to require 0.5% by mass or less in an oil gelling agent and wherein the composition exhibits a spreading area per 0.1mL of 12 cm2 or more. As a result of the amendment, applicant argues that Chen et al. “cannot affect the patentability of the present claims” (See Remarks filed 10/02/2026 at p. 8) Applicant’s arguments with respect to the claims have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Any inquiry concerning this communication or earlier communications from the examiner should be directed to WALTER E WEBB whose telephone number is (571)270-3287 and fax number is (571) 270-4287. The examiner can normally be reached from Mon-Fri 7-3:30. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sahana Kaup can be reached (571) 272-6897. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Walter E. Webb /WALTER E WEBB/ Primary Examiner, Art Unit 1612
Read full office action

Prosecution Timeline

Jan 29, 2024
Application Filed
Jun 02, 2026
Non-Final Rejection mailed — §102
Aug 20, 2026
Applicant Interview (Telephonic)
Aug 20, 2026
Examiner Interview Summary
Oct 02, 2026
Response Filed
Oct 02, 2026
Response after Non-Final Action
Oct 29, 2026
Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12797305
FLUORIDE COMPOSITION AND METHODS FOR DENTAL MINERALIZATION
4y 0m to grant Granted Nov 17, 2026
Patent 12778860
Delivery Carrier For Tooth Whitening
4y 11m to grant Granted Nov 03, 2026
Patent 12778874
Catalase Composition with Improved Stability and Methods
4y 1m to grant Granted Nov 03, 2026
Patent 12773379
METHODS OF USE OF ORAL CARE COMPOSITIONS COMPRISING HOPS
2y 5m to grant Granted Oct 27, 2026
Patent 12758476
ACID RESISTANT COMPOSITION HAVING IMPROVED SOLUBILITY
4y 4m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
46%
Grant Probability
65%
With Interview (+18.9%)
3y 4m (~6m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1007 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month